An interventional study of Art Pharmacy and Stable treatment in Depression in Adolescence, Anxiety and Loneliness, sponsored by SocialRx Inc. Not yet recruiting. Open to participants aged 15 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by SocialRx Inc · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.
The main question it aims to answer is:
Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.
Participants will:
Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.
Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).
If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.
4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.
This study's planned enrollment of 230 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →This is the only study on the registry with SocialRx Inc as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Participants must meet the following criteria:
Exclusion Criteria:
Participants will be excluded if they:
A personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app, SocialRx App
Behavioral: Art Pharmacy
Existing, stable treatment regimen without major changes
Other: Stable treatment
A personalized arts-based social prescribing program
Stable treatment (no change to existing care) through Medicaid managed care
Anxiety - Generalized Anxiety Disorder-7 (GAD-7)
The GAD-7 is a 7-item self-report measure of anxiety symptoms. Scores range from 0 to 21, with higher scores indicating greater anxiety severity.
Time frame: At baseline, and 3-, 6-, 9- and 12-month follow up.
Depression - Patient Health Questionnaire-9 Adolescent Version (PHQ-9A)
The PHQ-9A is a 9-item self-report measure of depressive symptoms in adolescents. Scores range from 0 to 27, with higher scores indicating greater depression severity.
Time frame: At baseline, and 3-, 6-, 9- and 12-month follow up.
Loneliness - UCLA Loneliness Scale
The UCLA Loneliness Scale assesses subjective feelings of loneliness and social isolation. Scores range from 20 - 80, with higher scores indicating a higher degree of loneliness.
Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up
Social Connectedness - Social Connectedness Scale-Revised (SCS-R)
The SCS-R measures feelings of interpersonal closeness and connectedness. Scores range from 20 to 120, with higher scores indicating greater social connectedness.
Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up
Treatment Utilization - Treatment and Arts/Cultural Engagement Utilization Questionnaire
A study-developed questionnaire assessing participant engagement with behavioral health treatment and arts/cultural activities. Higher scores/frequencies indicate greater utilization and engagement.
Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.